BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2013
View Archived Issues
Molecular InSight Pharmaceuticals prepares novel rhenium complexes
Read More
U.S. team discovers new monoacylglycerol lipase inhibitors
Read More
Reversal of apixaban anticoagulation with PRT-064445 in phase II study detailed
Read More
Transition Therapeutics licenses candidate for osteoarthritis pain from Lilly
Read More
Enrollment begins in phase II LGX-818 melanoma trial
Read More
FDA approves use of Hologic's Aptima HPV assay on fully automated Panther system
Read More
New Alzheimer's disease model is based on N-truncated Abeta4-42 expression
Read More
FDA accepts for review Merck & Co.'s vorapaxar NDA for secondary complications
Read More
Sarepta plans eteplirsen NDA submission
Read More
NOXXON's phase IIa study in diabetic nephropathy now fully enrolled
Read More
Reversal of oral anticoagulant activity with PER-977 described
Read More
Galectin begins dosing in phase I trial of GR-MD-02
Read More
Questcor to commence screening for phase II study of H.P. Acthar Gel in ALS
Read More
FDA grants orphan drug designation to Verastem's defactinib in mesothelioma
Read More
Fred Hutchinson Cancer Research Center receives National Cancer Institute grant
Read More
FDA advisory committee votes in favor of Cimzia for active axial spondyloarthritis
Read More
Northeastern University discloses new CB1 receptor modulators
Read More
Valproic acid analogue evaluated for antimigraine potential
Read More
InhibOx receives grant to develop novel therapies for multidrug-resistant infections
Read More
Allergan prepares new sodium channel blockers
Read More
Researchers at Complix patent novel polypeptides for cancer
Read More
Health Canada approves two GSK drugs for metastatic melanoma
Read More
Akebia Therapeutics commences phase IIb trial of oral HIF-PH inhibitor for anemia
Read More
New agents for tuberculosis synthesized by CSIR
Read More
Scientists at BioAlliance divulge new murine/human antibodies targeting TfR
Read More